JP2013523629A5 - - Google Patents

Download PDF

Info

Publication number
JP2013523629A5
JP2013523629A5 JP2013500647A JP2013500647A JP2013523629A5 JP 2013523629 A5 JP2013523629 A5 JP 2013523629A5 JP 2013500647 A JP2013500647 A JP 2013500647A JP 2013500647 A JP2013500647 A JP 2013500647A JP 2013523629 A5 JP2013523629 A5 JP 2013523629A5
Authority
JP
Japan
Prior art keywords
cys
thr
lys
phe
trp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2013500647A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013523629A (ja
Filing date
Publication date
Priority claimed from IE20100174A external-priority patent/IE20100174A1/en
Application filed filed Critical
Publication of JP2013523629A publication Critical patent/JP2013523629A/ja
Publication of JP2013523629A5 publication Critical patent/JP2013523629A5/ja
Ceased legal-status Critical Current

Links

JP2013500647A 2010-03-25 2011-03-23 ペプチドの経皮投与方法 Ceased JP2013523629A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE20100174A IE20100174A1 (en) 2010-03-25 2010-03-25 Transdermal administration of peptides
IE2010/0174 2010-03-25
PCT/IE2011/000019 WO2011117851A1 (en) 2010-03-25 2011-03-23 Transdermal administration of peptides

Publications (2)

Publication Number Publication Date
JP2013523629A JP2013523629A (ja) 2013-06-17
JP2013523629A5 true JP2013523629A5 (OSRAM) 2014-05-08

Family

ID=44210069

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013500647A Ceased JP2013523629A (ja) 2010-03-25 2011-03-23 ペプチドの経皮投与方法

Country Status (12)

Country Link
US (1) US20130085105A1 (OSRAM)
EP (1) EP2550005A1 (OSRAM)
JP (1) JP2013523629A (OSRAM)
KR (1) KR20130062275A (OSRAM)
CN (1) CN102883735A (OSRAM)
AU (1) AU2011231173A1 (OSRAM)
BR (1) BR112012022377A2 (OSRAM)
CA (1) CA2792470A1 (OSRAM)
IE (1) IE20100174A1 (OSRAM)
MX (1) MX2012010343A (OSRAM)
RU (1) RU2012145278A (OSRAM)
WO (1) WO2011117851A1 (OSRAM)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5486690B2 (ja) 2009-11-16 2014-05-07 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ メラノコルチン受容体リガンドの医薬組成物
MX343499B (es) * 2010-03-15 2016-11-08 Ipsen Pharma Sas Composiciones farmaceuticas de ligandos receptores de secretagoga de la hormona de crecimiento.
EP3106159A1 (en) 2010-05-12 2016-12-21 Radius Health, Inc. Therapeutic regimens
JP5965909B2 (ja) 2010-09-28 2016-08-10 ラジウス ヘルス,インコーポレイテッド 選択的アンドロゲン受容体モジュレーター
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9295637B2 (en) * 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
EP2979702A4 (en) * 2013-03-25 2016-11-16 Zeria Pharm Co Ltd GASTROKINETIC POSTPRANDIAL MEDIUM
CA2943611A1 (en) 2014-03-28 2015-10-01 Duke University Method of treating cancer using selective estrogen receptor modulators
PL3166967T3 (pl) * 2014-09-14 2023-07-24 Tel Hashomer Medical Research Infrastructure And Services Ltd. Syntetyczne ligandy receptora somatostatyny
CA2984357A1 (en) 2015-04-29 2016-11-03 Radius Pharmaceuticals, Inc. Methods for treating cancer
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
KR20190005199A (ko) 2016-05-05 2019-01-15 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
CA3027563C (en) 2016-06-22 2024-07-02 Ellipses Pharma Ltd AR+ METHODS FOR BREAST CANCER TREATMENT
JP7481115B2 (ja) 2017-01-05 2024-05-10 ラジウス ファーマシューティカルズ,インコーポレイテッド Rad1901-2hclの多形性形態
KR101786914B1 (ko) * 2017-01-31 2017-11-15 주식회사 삼양사 피부 리프팅 또는 탄력 개선을 위한 점착성 탄력 밴드
CN107226840A (zh) * 2017-05-04 2017-10-03 西安交通大学 一种细胞穿膜肽透皮吸收促进剂及其制备方法和应用
EP3687508A1 (en) * 2017-09-26 2020-08-05 Aquestive Therapeutics, Inc. Delivery pharmaceutical compositions including permeation enhancers
US11969460B2 (en) * 2018-06-08 2024-04-30 Saint Louis University Methods and compositions for treating decreased cognitive ability
IL279853B2 (en) 2018-07-04 2025-01-01 Radius Pharmaceuticals Inc Polymorphic forms of RAD 1901-2HCL
IT201800009384A1 (it) * 2018-10-11 2020-04-11 Cosmo Srl Peptide for cosmetic application
CN119390714A (zh) 2019-02-12 2025-02-07 雷迪厄斯制药公司 方法和化合物
DE102020130492A1 (de) * 2020-11-18 2022-05-19 Lts Lohmann Therapie-Systeme Ag. Temperiersystem für eine Diffusionszelle, Diffusionszelle, Diffusionszellensystem, sowie Verfahren zur Temperierung in einer Diffusionszelle
WO2023281447A1 (en) * 2021-07-07 2023-01-12 Radius Health, Inc. Methods of treating a cardiovascular ischemic event
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954975A (en) * 1972-02-17 1976-05-04 Ciba-Geigy Corporation Salts of ACTH-peptides and processes for their manufacture
IL79134A (en) * 1985-07-29 1991-06-10 American Cyanamid Co Continuous release peptide implants for parenteral administration
EP0671937A4 (en) * 1992-10-16 1996-09-18 Smithkline Beecham Corp COMPOSITIONS FOR PHARMACEUTICAL EMULSIONS.
US6316414B1 (en) * 2000-07-31 2001-11-13 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
CA2450446A1 (en) * 2001-06-25 2003-01-03 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R Pharmaceutical compositions which inhibit proliferation of pituitary adenomas and method of use thereof
US20030175329A1 (en) * 2001-10-04 2003-09-18 Cellegy Pharmaceuticals, Inc. Semisolid topical hormonal compositions and methods for treatment
WO2006040447A1 (fr) * 2004-10-07 2006-04-20 L'oreal Procédé de traitement cosmétique des fibres kératiniques et utilisation d'un inhibiteur de transglutaminase
US20060216242A1 (en) * 2005-02-03 2006-09-28 Rohloff Catherine M Suspending vehicles and pharmaceutical suspensions for drug dosage forms
AU2007233116B2 (en) * 2006-03-30 2013-05-09 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
WO2008008363A1 (en) * 2006-07-11 2008-01-17 Qps, Llc Pharmaceutical compositions for sustained release delivery of peptides
GB0705264D0 (en) * 2007-03-20 2007-04-25 Pliva Istrazivanje I Razvoj D Gel forming compounds
US20100196264A1 (en) * 2007-05-18 2010-08-05 The Brigham And Women's Hospital, Inc. Use of somatostatin analogs in myocardial perfusion imaging
WO2009100222A1 (en) * 2008-02-08 2009-08-13 Qps Llc Non-polymeric compositions for controlled drug delivery

Similar Documents

Publication Publication Date Title
JP2013523629A5 (OSRAM)
RU2012145278A (ru) Трансдермальное введение пептидов
JP2010526190A5 (OSRAM)
AR067701A1 (es) Metodos y composiciones utiles para la preparacion de inhibidores del contransportador de sodio y glucosa 2
JP2012211164A5 (OSRAM)
TW200800143A (en) Phenylephrine liquid formulations
JP2012502037A5 (OSRAM)
MX385798B (es) Composiciones orales que contienen un ester de 17-hidroxiprogesterona y metodos relacionados.
WO2010051541A3 (en) Compositions containing delta-9-thc-amino acid esters and process of preparation
JP2009502025A5 (OSRAM)
JP2009545527A5 (OSRAM)
JP2010090168A5 (OSRAM)
UY39192A (es) Dispersión sólida, proceso para prepararla y forma de dosificación farmacéutica suministrable por vía oral que la comprende
WO2016210003A3 (en) 17-hydroxyprogesterone ester-containing oral compositions and related methods
JPWO2000038731A1 (ja) 外用剤
JP2011510048A (ja) 低減したアルコール相互作用を有する乱用抵抗性溶融押出製剤
UA105057C2 (uk) Композиція 1-[2-(2,4-диметилфенілсульфаніл)феніл]-піперазину
CN103384518A (zh) 新的抗真菌组合物
JP2009532434A5 (OSRAM)
JP2015535274A5 (OSRAM)
JP2013530208A5 (OSRAM)
JPWO2008081829A1 (ja) 難水溶性薬物の溶解性維持用アミノアルキルメタアクリレートコポリマーe
CN1681534A (zh) 药物吸收性改善剂
JP2009527467A5 (OSRAM)
CN110139641A (zh) 外用组合物